Helping an Israeli Biotech Company Raise Funds in the United States

ZAG/S&W assisted client Pluristem Therapeutics Inc. (Nasdaq:PSTI - News) (DAX:PJT) (TASE:PLTR), a clinical stage biotechnology company with proprietary technology for the development and manufacturing of standardized cell therapies derived from the human placenta, with two recent private placements, one worth $2.7 million and another worth $3.1 million. In addition, we assisted Pluristem with its listing on the Tel-Aviv Stock Exchange.

ZAG/S&W’s unique structure, seamless integration between Israel and the United States and strength in the Israeli biotech sector eased the transaction to completion.